RENAE TABIN: Open Payments
NPI 1467636787 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 21 payments from 8 companies in 2025. Trend: 2023 $4,647 · 2024 $7,711 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $168 |
| UCB, Inc. | 2 | $83 |
| ARGENX US, INC. | 2 | $68 |
| SK Life Science, Inc. | 2 | $59 |
| PFIZER INC. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| MDD US Operations, LLC | 1 | $24 |
Products named: QULIPTA, VYVGART HYTRULO, Fintepla, Briviact, KESIMPTA, NURTEC ODT, Xeomin, PANZYGA.
Industry payments across CO — which companies pay providers there.
